Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$151.44 - $200.09 $6,814 - $9,004
-45 Reduced 1.78%
2,487 $490,000
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $47,634 - $54,939
-285 Reduced 10.12%
2,532 $440,000
Q2 2023

Aug 08, 2023

BUY
$160.94 - $186.23 $112,014 - $129,616
696 Added 32.81%
2,817 $485,000
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $19,670 - $23,620
-150 Reduced 6.61%
2,121 $310,000
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $18,091 - $22,271
-122 Reduced 5.1%
2,271 $337,000
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $26,046 - $33,415
167 Added 7.5%
2,393 $411,000
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $562,490 - $725,727
-3,101 Reduced 58.21%
2,226 $420,000
Q4 2021

Feb 09, 2022

SELL
$193.69 - $247.03 $128,610 - $164,027
-664 Reduced 11.08%
5,327 $1.3 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $138,560 - $153,493
-732 Reduced 10.89%
5,991 $1.16 Million
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $56,747 - $68,428
-364 Reduced 5.14%
6,723 $1.25 Million
Q1 2021

May 11, 2021

SELL
$144.0 - $169.39 $1.2 Million - $1.41 Million
-8,312 Reduced 53.98%
7,087 $1.12 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $3.83 Million - $4.25 Million
-24,365 Reduced 61.27%
15,399 $2.55 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $2.31 Million - $2.79 Million
-16,862 Reduced 29.78%
39,764 $6.58 Million
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $708,015 - $1.11 Million
-7,641 Reduced 11.89%
56,626 $6.66 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $3.15 Million - $3.61 Million
-27,092 Reduced 29.65%
64,267 $8.51 Million
Q3 2019

Nov 13, 2019

SELL
$112.57 - $128.43 $545,401 - $622,243
-4,845 Reduced 5.04%
91,359 $11.4 Million
Q2 2019

Aug 12, 2019

BUY
$97.98 - $114.28 $2.05 Million - $2.39 Million
20,925 Added 27.8%
96,204 $10.9 Million
Q1 2019

May 08, 2019

SELL
$81.56 - $100.67 $7,666 - $9,462
-94 Reduced 0.12%
75,279 $7.58 Million
Q4 2018

Feb 07, 2019

SELL
$79.28 - $95.27 $5.24 Million - $6.3 Million
-66,128 Reduced 46.73%
75,373 $6.45 Million
Q3 2018

Oct 26, 2018

SELL
$83.5 - $93.23 $3.13 Million - $3.5 Million
-37,532 Reduced 20.96%
141,501 $13 Million
Q2 2018

Aug 03, 2018

BUY
$79.9 - $89.2 $546,196 - $609,771
6,836 Added 3.97%
179,033 $15.3 Million
Q1 2018

May 04, 2018

BUY
$71.51 - $84.69 $608,121 - $720,203
8,504 Added 5.2%
172,197 $14.4 Million
Q4 2017

Feb 08, 2018

BUY
$63.24 - $72.8 $3.66 Million - $4.21 Million
57,883 Added 54.7%
163,693 $11.8 Million
Q3 2017

Nov 13, 2017

SELL
$59.73 - $65.4 $1.04 Million - $1.14 Million
-17,400 Reduced 14.12%
105,810 $6.75 Million
Q2 2017

Aug 15, 2017

SELL
N/A
-138,880 Reduced 52.99%
123,210 $7.69 Million
Q2 2017

Aug 14, 2017

BUY
N/A
262,090
262,090 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Barings LLC Portfolio

Follow Barings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.